Clinical trial
Biochemical Markers of Growth Response to Growth Hormone Treatment in Children…
NCT00458263 · Rabin Medical Center, Other · Completed
Key facts
| NCT number | NCT00458263 |
|---|---|
| Title | Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature |
| Official title | One Arm, Open Study to Assess Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature |
| Acronym | ISS |
| Lead sponsor | Rabin Medical Center, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Idiopathic Short Stature |
| Intervention type | Drug |
| Interventions | Somatotropin growth hormone recombinant human |
| Enrollment | 21 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Apr 10, 2007 |
| Last update posted | Jan 3, 2013 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: